James P. Hoey and Joseph K. Jachinowski, ROI Trustees
We had the pleasure of providing matching gifts for the 2018 Giving Tuesday effort for the Radiation Oncology Institute (ROI). This year marks the first time that the ROI has participated in the global day of giving. After the shopping on Black Friday and Cyber Monday, the Tuesday after Thanksgiving is designated as a day for giving back. Highlights of #GivingTuesday for the ROI included a social media campaign, “unselfies,” and online giving. The generous contributions on Giving Tuesday totaled $7,150, including the matching funds. The venture was a great kickoff for year-end giving.
Between now and December 31, 2018, we hope you will consider making a generous gift to the ROI. Please take time to read the letter about our research and its importance in the care of your patients that was mailed to ASTRO members last month. In it, you can learn about the ROI’s recently funded research study on using telehealth to increase access to the radiation oncology survivorship program at Vanderbilt-Ingram Cancer Center. The response to the letter has been positive and year-end contributions are beginning to arrive at the ROI.
While tax laws have changed, charitable giving is still advantageous if you itemize your taxes. The end of the year is a good time to consider gifts of appreciated securities. You can get the full value of the stock as a charitable deduction and avoid paying tax on the capital gains.
If you are 70½ or older, you can make a direct contribution from an IRA to the ROI that will meet your required minimum distribution and will not increase your taxable income for the year.
When you are reviewing your financial plans for the year, you may also want to consider making a provision for the ROI that will benefit the organization in the future. An article on ways to make these gifts is included in this newsletter.
In whatever way you choose to support the ROI, you are helping to fund applied research that has an impact on your patients’ quality of life and on the outcomes that they experience with radiation therapy. Since 2010, the ROI has funded over $3 million in research in radiation oncology. With your support, we can continue to support studies that advance the field of radiation oncology and the care you can provide to your patients.
Make your gift today
and support research in radiation oncology!
James P. Hoey is a former industry executive and Joseph K. Jachinowski is Executive Director of Mevion Medical Systems.